Synta Pharmaceuticals Corp.
) was a big mover last session, as the company saw its shares rise
by over 15% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This reverses
the recent trend for the company, as the stock is now down over 28%
in the past one-month time frame.
This biopharmaceutical company has seen 1 negative revision in the
past one month, while two estimates moved north. However, its Zacks
Consensus Estimate moved lower over the same period, suggesting
there may be trouble down the road. So make sure to keep an eye on
this stock going forward to see if yesterday's move higher can
Synta Pharmaceuticals currently has a Zacks Rank #3 (Hold) while
Investors interested in the med-biomed industry may consider stocks
AMAG Pharmaceuticals, Inc.
Gilead Sciences Inc.
). While AMAG Pharmaceuticals and Heska Corporation hold a Zacks
Rank #1 (Strong Buy), Gilead Sciences carries a Zacks Rank #2
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
AMAG PHARMA INC (AMAG): Free Stock Analysis
GILEAD SCIENCES (GILD): Free Stock Analysis
HESKA CORP (HSKA): Free Stock Analysis Report
SYNTA PHARMACT (SNTA): Free Stock Analysis
To read this article on Zacks.com click here.